Gentuity and GE HealthCare to Collaborate on Intravascular Imaging Platform Commercialization

August 11, 2025—Gentuity LLC, a developer of intravascular imaging devices, recently announced an agreement with GE HealthCare to collaborate on commercial activities. The collaboration is intended to enhance the availability, adoption, and functionality of complementary imaging solutions for interventional cardiology, stated the company.

According to the press release, Gentuity and GE HealthCare will aim to jointly pursue comarketing initiatives and technical integration of their respective technologies. GE HealthCare also plans to explore opportunities to expand access to Gentuity’s products through its own distribution network in the United States.

The Genuity products include its high-frequency optical coherence tomography (HF-OCT) imaging system and Vis-Rx Prime microimaging catheter.

In October 2024, Gentuity, announced FDA 510(k) clearance for its HF-OCT imaging system featuring the 1.8-F Vis-Rx catheter for assessment of coronary vessels both before and after percutaneous coronary intervention.